Related Experiment Video
Updated: Jul 7, 2025
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Evaluation of corticophobia in patients with atopic dermatitis and psoriasis using the TOPICOP© score
Mateja Starbek Zorko1,2, Maja Benko1, Mateja Rakuša3
1Department of Dermatology, Ljubljana University Medical Center, Ljubljana, Slovenia.
Introduction:
Atopic dermatitis (AD) and psoriasis (PS) are skin diseases that have a significant impact on the quality of life. The correct application of corticosteroids in topical treatment is highly effective and safe for patients. Excessive and irrational fear of these drugs based on incorrect information is increasingly observed at dermatological clinics.
Methods:
To assess the extent of corticophobia, we conducted a single-center cross-sectional survey using the TOPICOP© questionnaire.
Results:
The study included 57 patients (56% female) with AD and 58 patients (60% female) with PS. The combined TOPICOP© score averaged around 44, showing no significant difference between the two skin conditions. However, consistently higher scores were observed among female participants compared to males.
Conclusions:
The prevalence of corticophobia was comparable to that reported in other similar studies and was higher among female patients, which replicates previous findings. Patients with AD, who were younger on average than patients with PS, often relied on friends, acquaintances, family members, and the internet as their main information sources. Providing correct and reliable information to patients is crucial for ensuring treatment adherence.
